Literature DB >> 12819382

Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors.

Chung-Ho Lee1, Oh-Kyeong Kweon.   

Abstract

Mutation of the p53 tumor suppressor gene has been related in the pathogenesis of numerous human and canine cancers, including breast cancers and mammary tumors. We have investigated exons 5-8 of the p53 gene for mutations in 20 spontaneous canine mammary tumors using polymerase chain reaction (PCR) with direct sequence analysis to evaluate the role of this gene in canine mammary tumorigenesis and analyzed to compare with other clinicopathological parameters including age, histology, stage, recurrence and death from tumor. Four missense (one case had two missense mutations) and one nonsense mutations were detected in 10 malignant lesions (40%), and two missense and one silent mutations were found in 10 benign mammary tumors (30%). Five of the missense mutations were located in highly conserved domains II, III, IV and V. After a follow-up period, four dogs showed a progression and three of these patients revealed death from mammary carcinoma with p53 mutation. These results demonstrated that the p53 gene mutations might be involved in the development of canine mammary tumors and contribute to the prognostic status in canine mammary carcinomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12819382

Source DB:  PubMed          Journal:  J Vet Sci        ISSN: 1229-845X            Impact factor:   1.672


  8 in total

1.  Histological classification and expression of markers of canine mast cell tumors.

Authors:  V S Cruz; J C A Borges; L L Nepomuceno; P A M Gonçalves; Y C L Prado; C Bianchi; M C S Fioravanti; E G Araújo
Journal:  Vet World       Date:  2020-08-18

Review 2.  Comparative oncology today.

Authors:  Melissa C Paoloni; Chand Khanna
Journal:  Vet Clin North Am Small Anim Pract       Date:  2007-11       Impact factor: 2.093

3.  Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index.

Authors:  Giorgia Beffagna; Alessandro Sammarco; Chiara Bedin; Chiara Romualdi; Marta Mainenti; Antonio Mollo; Laura Cavicchioli; Silvia Ferro; Davide Trez; Raffaella De Maria; Donato Nitti; Andrea Saccani; Michelangelo Campanella; Marco Agostini; Valentina Zappulli
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

Review 4.  Canine mammary tumors as a model for human disease.

Authors:  Somaia M Abdelmegeed; Sulma Mohammed
Journal:  Oncol Lett       Date:  2018-04-02       Impact factor: 2.967

Review 5.  DNA damage response proteins in canine cancer as potential research targets in comparative oncology.

Authors:  Beatriz Hernández-Suárez; David A Gillespie; Aleksandra Pawlak
Journal:  Vet Comp Oncol       Date:  2022-01-10       Impact factor: 2.385

6.  Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine.

Authors:  Judit Fazekas; Irene Fürdös; Josef Singer; Erika Jensen-Jarolim
Journal:  Oncol Lett       Date:  2016-08-11       Impact factor: 2.967

7.  Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq.

Authors:  Shingo Maeda; Hirotaka Tomiyasu; Masaya Tsuboi; Akiko Inoue; Genki Ishihara; Takao Uchikai; James K Chambers; Kazuyuki Uchida; Tomohiro Yonezawa; Naoaki Matsuki
Journal:  BMC Cancer       Date:  2018-04-27       Impact factor: 4.430

Review 8.  Naturally-Occurring Canine Mammary Tumors as a Translational Model for Human Breast Cancer.

Authors:  Mark Gray; James Meehan; Carlos Martínez-Pérez; Charlene Kay; Arran K Turnbull; Linda R Morrison; Lisa Y Pang; David Argyle
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.